Table IIB.

Percent of cells with ≥2 PARP1 staining analyzed according to patient and tumor characteristics (Race, ER status, PR status, HER2 status).

		Number	Mean	Std Dev	Median	Minimum	Maximum	LSMean	P-value
Race	White	152	33.51	33.79	20	0	100	26.41	0.5577
	Black	154	24.92	31.55	8.33	0	100	24.32
	Other	1	0	---	0	0	0	−7.65
ER	ER+	138	24.23	31.04	5	0	100	11.00	0.4212
	ER-	169	32.92	33.81	20	0	100	17.72
PR	PR+	128	24.25	31.00	5.83	0	100	15.50	0.7863
	PR-	179	32.47	33.78	20	0	100	13.21
HER2	HER2+	93	31.52	30.52	20	0	98.33	20.25	0.0095
	HER2-	214	28.06	33.90	10	0	100	8.47
Stage	0	1	30	---	30	30	30	−1.64	0.6423
	1	77	36.93	36.46	20	0	100	21.24
	2	143	28.27	32.48	13.33	0	100	18.95
	3	74	23.33	29.62	10	0	100	13.10
	4	5	30	39.65	23.33	0	96.67	20.16